C. R. Bard Inc (BCR)-Product Pipeline Analysis, 2017 Update
Region:North America
Product Code:GDME522PD
April 2017
83
About the Report
C. R. Bard Inc (Bard) is a medical device company which designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. It offers products related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. The company offers its comprehensive range of products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company conducts its operations in Americas, Europe, Asia pacific, the Middle East and Africa. It has international manufacturing facilities in Puerto Rico, Germany, France, Belgium, Mexico and Malaysia. Bard is headquartered in Murray Hill, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company C. R. Bard Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Scope of the Report
Companies
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
C. R. Bard Inc Company Overview 8
C. R. Bard Inc Company Snapshot 8
C. R. Bard Inc Pipeline Products and Ongoing Clinical Trials Overview 8
C. R. Bard Inc-Pipeline Analysis Overview 11
Business Description 11
C. R. Bard Inc-Key Facts 11
C. R. Bard Inc-Major Products and Services 12
C. R. Bard Inc Pipeline Products by Development Stage 14
C. R. Bard Inc Ongoing Clinical Trials by Trial Status 17
C. R. Bard Inc Pipeline Products Overview 19
Anti-Microbial Titanium PowerPort 19
Anti-Microbial Titanium PowerPort Product Overview 19
Anti-Thrombotic PICCs 20
Anti-Thrombotic PICCs Product Overview 20
Antimicrobial PICC 21
Antimicrobial PICC Product Overview 21
BARD HD MESH Mapper Catheter 22
BARD HD MESH Mapper Catheter Product Overview 22
Bard LifeStent 5F Vascular Stent System 23
Bard LifeStent 5F Vascular Stent System Product Overview 23
Bard LifeStent 5F Vascular Stent System Clinical Trial 24
Caterpillar 25
Caterpillar Product Overview 25
Covera Vascular Covered Stent Graft 26
Covera Vascular Covered Stent Graft Product Overview 26
COVERT PowerPICC 27
COVERT PowerPICC Product Overview 27
Dual Lumen PowerPort 28
Dual Lumen PowerPort Product Overview 28
ECHO 2.0 29
ECHO 2.0 Product Overview 29
EnCor Mini 30
EnCor Mini Product Overview 30
Fever Management Device 31
Fever Management Device Product Overview 31
Geo-Align Marking System 32
Geo-Align Marking System Product Overview 32
Internal Jugular Placement Catheter 33
Internal Jugular Placement Catheter Product Overview 33
Lifestream Stent Graft 34
Lifestream Stent Graft Product Overview 34
Loc Wire Replacement 35
Loc Wire Replacement Product Overview 35
Lutonix-AV 36
Lutonix-AV Product Overview 36
Lutonix-ISR 37
Lutonix-ISR Product Overview 37
Lutonix 014 DCB Catheter 38
Lutonix 014 DCB Catheter Product Overview 38
Lutonix 014 DCB Catheter Clinical Trial 39
LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions 41
LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions Product Overview 41
LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions Clinical Trial 42
Marquee 43
Marquee Product Overview 43
Minimally Invasive Cutting Instrumentation 44
Minimally Invasive Cutting Instrumentation Product Overview 44
New Fixation Device 45
New Fixation Device Product Overview 45
New Hemostat 1 46
New Hemostat 1 Product Overview 46
New Hemostat 2 47
New Hemostat 2 Product Overview 47
Next-generation Radiation Therapy 48
Next-generation Radiation Therapy Product Overview 48
Phasix Expansion 49
Phasix Expansion Product Overview 49
PowerPort-Low-Profile Version 50
PowerPort-Low-Profile Version Product Overview 50
Progel Dural Sealant 51
Progel Dural Sealant Product Overview 51
Progel Emerald 52
Progel Emerald Product Overview 52
ProGEL-VS 53
ProGEL-VS Product Overview 53
Restore Suturing System 54
Restore Suturing System Product Overview 54
RFID Tag Device 55
RFID Tag Device Product Overview 55
RFID Tag Device Clinical Trial 56
sideKicK Side Branch Protection System 57
sideKicK Side Branch Protection System Product Overview 57
Transformational Fixation 58
Transformational Fixation Product Overview 58
Tridyne Peripheral 59
Tridyne Peripheral Product Overview 59
Ultrascore 60
Ultrascore Product Overview 60
Venovo PTA Catheter 61
Venovo PTA Catheter Product Overview 61
VENOVO Venous Stent 62
VENOVO Venous Stent Product Overview 62
VIVEXX Carotid Stent 63
VIVEXX Carotid Stent Product Overview 63
XenMatrix AB LX 64
XenMatrix AB LX Product Overview 64
C. R. Bard Inc-Key Competitors 65
C. R. Bard Inc-Key Employees 66
C. R. Bard Inc-Key Employee Biographies 68
C. R. Bard Inc-Locations And Subsidiaries 69
Head Office 69
Other Locations & Subsidiaries 69
Business Unit 73
Recent Developments 74
C. R. Bard Inc, Recent Developments 74
Jan 30, 2017: Bard Peripheral Vascular Recalls Halo One Thin-Walled Guiding Sheath Due to Sheath Separation, Kinking, or Tip Damage 74
Jan 26, 2017: Bard Announces Fourth Quarter Results 74
Oct 25, 2016: Bard Announces Third Quarter Results 75
Sep 22, 2016: LUTONIX Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 75
Sep 19, 2016: FDA Approves 6-Month Primary End Point For The Lutonix Below-the-Knee Drug Coated Balloon 76
Jul 26, 2016: Bard Announces Second Quarter Results 76
Apr 27, 2016: Bard Announces First Quarter Results 77
Feb 09, 2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 78
Jan 29, 2016: Bard Announces Fourth Quarter Results 78
Jan 08, 2016: Seeger Weiss LLP Reports That IVC Filter Lawsuits Against C.R. Bard Have Been Consolidated In A Multidistrict Litigation 79
Appendix 80
Methodology 80
About GlobalData 82
Contact Us 82
Disclaimer 82
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.